Amicus Therapeutics Inc
F:AM6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amicus Therapeutics Inc
F:AM6
|
US |
|
I
|
Intermedical Care and Lab Hospital PCL
SET:IMH
|
TH |
|
F
|
First Growth Funds Ltd
OTC:MTOMF
|
AU |
|
G
|
Genesis Fertility Center PCL
SET:GFC
|
TH |
|
E
|
E for L Aim PCL
SET:EFORL
|
TH |
|
G
|
Green Tech Ventures PCL
SET:GTV
|
TH |
|
Intracom Holdings SA
F:INTA
|
GR |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
I
|
International Network System PCL
SET:ITNS
|
TH |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
A
|
Arrow Syndicate PCL
SET:ARROW
|
TH |
|
N
|
Nxera Pharma Co Ltd
F:JSS
|
JP |
|
P
|
Polledo Sociedad Anonima Industrial Constructora y Financiera
BCBA:POLL
|
AR |
|
C
|
Chememan PCL
SET:CMAN
|
TH |
|
H
|
Hextar Technologies Solutions Bhd
KLSE:HEXTECH
|
MY |
Bankruptcy Probability
Amicus Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amicus Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
Amicus Therapeutics Inc
F:AM6
|
3.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
484.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
86.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amicus Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amicus Therapeutics Inc has total debt of 392.7m USD. This includes both short-term (0 USD) and long-term (392.7m USD) debt.
You can find a full breakdown on its Balance Sheet.